GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin delivery feature to predict and help prevent high and low blood sugar.

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.